CALL/MERCK & CO./160/0.1/17.01.25 Stock

Warrant

DE000GP7C460

Market Closed - BOERSE MUENCHEN 02:27:16 2024-06-26 pm EDT
0.106 EUR -7.83% Intraday chart for CALL/MERCK & CO./160/0.1/17.01.25
Current month+53.62%
1 month+17.78%
Date Price Change
24-06-26 0.106 -7.83%
24-06-25 0.115 +16.16%
24-06-24 0.099 +23.75%
24-06-21 0.08 +5.26%
24-06-20 0.076 +18.75%

Real-time BOERSE MUENCHEN

Last update June 26, 2024 at 02:27 pm EDT

More quotes

Static data

Product typeWarrant Plain-Vanilla
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Goldman Sachs
WKN GP7C46
ISINDE000GP7C460
Date issued 2023-06-29
Strike 160 $
Maturity 2025-01-17 (205 Days)
Parity 10 : 1
Emission price 0.11
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.195
Lowest since issue 0.019
Spread 0.02
Spread %16.67%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.5 USD
Average target price
142.7 USD
Spread / Average Target
+8.50%
Consensus